These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10615665)

  • 1. [F-18-FDG PET for primary diagnosis differential diagnosis of pleural processes].
    Buchmann I; Guhlmann CA; Elsner K; Gfrörer W; Schirrmeister H; Kotzerke J; Buck A; Reske SN
    Nuklearmedizin; 1999; 38(8):319-22. PubMed ID: 10615665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical role of F-18 fluorodeoxyglucose positron emission tomography imaging in patients with lung cancer and suspected malignant pleural effusion.
    Gupta NC; Rogers JS; Graeber GM; Gregory JL; Waheed U; Mullet D; Atkins M
    Chest; 2002 Dec; 122(6):1918-24. PubMed ID: 12475827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of 18F-FDG PET/CT Integrated Imaging in Distinguishing Malignant from Benign Pleural Effusion.
    Sun Y; Yu H; Ma J; Lu P
    PLoS One; 2016; 11(8):e0161764. PubMed ID: 27560933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical value of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiation of malignant mesothelioma from asbestos-related benign pleural disease: an observational pilot study.
    Yildirim H; Metintas M; Entok E; Ak G; Ak I; Dundar E; Erginel S
    J Thorac Oncol; 2009 Dec; 4(12):1480-4. PubMed ID: 19875971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDG PET of pleural effusions in patients with non-small cell lung cancer.
    Erasmus JJ; McAdams HP; Rossi SE; Goodman PC; Coleman RE; Patz EF
    AJR Am J Roentgenol; 2000 Jul; 175(1):245-9. PubMed ID: 10882281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of FDG PET-CT in differential diagnosis of pleural pathologies.
    Elboga U; Yılmaz M; Uyar M; Zeki Çelen Y; Bakır K; Dikensoy O
    Rev Esp Med Nucl Imagen Mol; 2012; 31(4):187-91. PubMed ID: 23067687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of F-18 FDG PET/CT for malignant pleural effusion in non-small cell lung cancer patients.
    Kim BS; Kim IJ; Kim SJ; Pak K; Kim K
    Onkologie; 2011; 34(6):298-303. PubMed ID: 21625182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of pleural disease with 18-fluorodeoxyglucose positron emission tomography imaging.
    Duysinx B; Nguyen D; Louis R; Cataldo D; Belhocine T; Bartsch P; Bury T
    Chest; 2004 Feb; 125(2):489-93. PubMed ID: 14769729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of malignant pleural mesothelioma with (18)F-FDG dual-head gamma-camera coincidence imaging: comparison with histopathology.
    Gerbaudo VH; Sugarbaker DJ; Britz-Cunningham S; Di Carli MF; Mauceri C; Treves ST
    J Nucl Med; 2002 Sep; 43(9):1144-9. PubMed ID: 12215551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of the PET-CT score for diagnosis of malignant pleural effusion.
    Yang MF; Tong ZH; Wang Z; Zhang YY; Xu LL; Wang XJ; Li W; Wu XZ; Wang W; Zhang YH; Jiang T; Shi HZ
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1457-1467. PubMed ID: 30903197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical Layering of FDG in Pleural Effusion.
    Han EJ; Yoon H; Choi WH
    Clin Nucl Med; 2024 Feb; 49(2):162-165. PubMed ID: 37976534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled prospective study of positron emission tomography using the glucose analogue [18f]fluorodeoxyglucose in the evaluation of pulmonary nodules.
    Präuer HW; Weber WA; Römer W; Treumann T; Ziegler SI; Schwaiger M
    Br J Surg; 1998 Nov; 85(11):1506-11. PubMed ID: 9823912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical role of F-18 FDG PET/CT in differentiating malignant and benign pleural effusion in patients with lung cancer].
    Liao R; Yang X; Wang S; Zhou Q; Nie Q; Zhong W; Dong S; Wu Y
    Zhongguo Fei Ai Za Zhi; 2012 Nov; 15(11):652-5. PubMed ID: 23164351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-FDG PET imaging in assessing exudative pleural effusions.
    Duysinx BC; Larock MP; Nguyen D; Corhay JL; Bury T; Hustinx R; Louis R
    Nucl Med Commun; 2006 Dec; 27(12):971-6. PubMed ID: 17088683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Imaging of secondary pulmonary changes in central bronchial carcinomas by F-18-FDG PET].
    Briele B; Willkomm P; Grünwald F; Ruhlmann J; Biersack HJ
    Nuklearmedizin; 1999; 38(8):323-7. PubMed ID: 10615666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography.
    Bénard F; Sterman D; Smith RJ; Kaiser LR; Albelda SM; Alavi A
    Chest; 1998 Sep; 114(3):713-22. PubMed ID: 9743156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of FDG positron emission tomography for differentiation of unknown pulmonary lesions.
    Imdahl A; Jenkner S; Brink I; Nitzsche E; Stoelben E; Moser E; Hasse J
    Eur J Cardiothorac Surg; 2001 Aug; 20(2):324-9. PubMed ID: 11463551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Ability of FDG-PET/CT in the Detection of Malignant Pleural Effusion.
    Nakajima R; Abe K; Sakai S
    Medicine (Baltimore); 2015 Jul; 94(29):e1010. PubMed ID: 26200610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron emission tomographic imaging with fluorodeoxyglucose isefficacious in evaluating malignant pulmonary disease.
    Graeber GM; Gupta NC; Murray GF
    J Thorac Cardiovasc Surg; 1999 Apr; 117(4):719-27. PubMed ID: 10096967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is 18F-FDG PET/CT capable of differential diagnosis from tuberculous pleurisy from malignant mesothelioma?
    Özmen Ö; Tatci E; Demiröz ŞM; Tazeler Z; Demirağ F
    Nucl Med Commun; 2021 Jun; 42(6):672-677. PubMed ID: 33625184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.